Brand Name: COAPTIUM CONNECT Product Name: COAPTIUM CONNECT Recall
Brand Name: COAPTIUM CONNECT Product Name: COAPTIUM CONNECT Model/Catalog Number: NCOCO3010 Software Version: N/A Product Description: In situ polymerizing peripheral nerve repair device Component: No
FDA recall Class II
Ongoing
FDA lists this Class II recall for Brand Name: COAPTIUM CONNECT Product Name: COAPTIUM CONNECT. Review the affected identifiers, reported reason and manufacturer instructions below.
Recall at a glance
- Recall number
- Z-2905-2026
- Recall classification
- Class II
- Enforcement status
- Ongoing
- Initiation date
- Jun 15, 2026
- FDA report date
- Aug 12, 2026
- Quantity in commerce
- Not reported
- Distribution
- See key details
- FDA cause
- Incorrect or no expiration date
What is being recalled?
Brand Name: COAPTIUM CONNECT Product Name: COAPTIUM CONNECT Model/Catalog Number: NCOCO3010 Software Version: N/A Product Description: In situ polymerizing peripheral nerve repair device Component: No
Affected model & UDI checker
Search the exact identifiers published for Z-2905-2026.
The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.
Affected products
| Model / catalog number | Product | Lot scope reported | UDI / GTIN |
|---|---|---|---|
| NCOCO3010 | Brand Name: COAPTIUM CONNECT Product Name: COAPTIUM CONNECT | Check source notice | Not specified |
| Not specified | Brand Name: COAPTIUM CONNECT Product Name: COAPTIUM CONNECT | Check source notice | 03760279380117 |
FDA code information
Lot Code: Model No NCOCO3010; UDI-DI 03760279380117; Lot Numbers 250700045, 251000040, 251000036, 251000037, 251000039, 251000035, and 251000064
Why was this product recalled?
Currently labeled shelf life of 36 months is not substantiated by real-time data. Devices will be relabeled to reflect revised shelf life of 26 months. The use of a medical device beyond its validated shelf life may result in perioperative breakage of the device rendering device unusable; worst-case outcome would be revision surgery.
These are potential consequences described in the source. The recall reason does not establish how many injuries or incidents occurred.
What actions did TISSIUM SA take?
On June 25, 2026, the firm began notifying consignees via direct visit by medical representatives to deliver the Customer Recall Notification Letter in person. Representatives removed affected units from customer shelves, collected completed response forms, and provided conforming replacement product on the same day.
Read the manufacturer action recorded by FDARecall timeline
Recall initiated by firm
FDA notice posted
FDA classification recorded
FDA enforcement report date
Related FDA submissions
No submission number with an exact verified relationship is linked in the retrieved recall notice.
FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.
Source and update history
- FDA recall notice Z-2905-2026
- openFDA enforcement record · Source release Nov 11, 2026 · Retrieved Nov 21, 2026
- openFDA device recall record · Source release Nov 19, 2026 · Retrieved Nov 21, 2026
- FDA enforcement data
First stored snapshot of this source.
- FDA device-recall notice
First stored snapshot of this source.
The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.
Our data sources and methodology